FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex.

A BAC located in the 16q24.3 breast cancer loss of heterozygosity region was previously shown to restore cellular senescence when transferred into breast tumor cell lines. We have shown that FBXO31, although located just distal to this BAC, can induce cellular senescence in the breast cancer cell line MCF-7 and is the likely candidate senescence gene. FBXO31 has properties consistent with a tumor suppressor, because ectopic expression of FBXO31 in two breast cancer cell lines inhibited colony growth on plastic and inhibited cell proliferation in the MCF-7 cell line. In addition, compared with the relative expression in normal breast, levels of FBXO31 were down-regulated in breast tumor cell lines and primary tumors. FBXO31 was cell cycle regulated in the breast cell lines MCF-10A and SKBR3 with maximal expression from late G(2) to early G(1) phase. Ectopic expression of FBXO31 in the breast cancer cell line MDA-MB-468 resulted in the accumulation of cells at the G(1) phase of the cell cycle. FBXO31 contains an F-box domain and is associated with the proteins Skp1, Roc-1, and Cullin-1, suggesting that FBXO31 is a component of a SCF ubiquitination complex. We propose that FBXO31 functions as a tumor suppressor by generating SCF(FBXO31) complexes that target particular substrates, critical for the normal execution of the cell cycle, for ubiquitination and subsequent degradation.

[1]  N. Doggett,et al.  Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes. , 2002, Genomics.

[2]  Timothy Cardozo,et al.  Systematic analysis and nomenclature of mammalian F-box proteins. , 2004, Genes & development.

[3]  M. Brandeis,et al.  Timing of APC/C substrate degradation is determined by fzy/fzr specificity of destruction boxes , 2002, The EMBO journal.

[4]  P. Yaswen,et al.  Human epithelial cell immortalization as a step in carcinogenesis. , 2003, Cancer letters.

[5]  K. Sakamoto,et al.  Analysis of DNA Content and Green Fluorescent Protein Expression , 2001, Current protocols in cytometry.

[6]  Simon C Watkins,et al.  Current Protocols In Cytometry , 1997 .

[7]  S. Elledge,et al.  A family of mammalian F-box proteins , 1999, Current Biology.

[8]  M. Vidal,et al.  Identification of a family of human F-box proteins , 1999, Current Biology.

[9]  A. Paige.  Redefining tumour suppressor genes: exceptions to the two-hit hypothesis , 2003, Cellular and Molecular Life Sciences CMLS.

[10]  A. Cleton-Jansen,et al.  Defining regions of loss of heterozygosity of 16q in breast cancer cell lines. , 2002, Cancer genetics and cytogenetics.

[11]  M. Pagano,et al.  Regulation of the G1 to S transition by the ubiquitin pathway , 2001, FEBS letters.

[12]  S. Reed,et al.  Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover , 2003, Nature Reviews Molecular Cell Biology.

[13]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[14]  Michele Pagano,et al.  SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27 , 1999, Nature Cell Biology.

[15]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[16]  N. O’Callaghan,et al.  CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. , 2002, Cancer research.

[17]  C. Keck,et al.  Identification of a YAC from 16q24 carrying a senescence gene for breast cancer cells , 2000, Oncogene.

[18]  D. Zimonjic,et al.  Functional identification of a BAC clone from 16q24 carrying a senescence gene SEN16 for breast cancer cells , 2005, Oncogene.

[19]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[20]  G. Dreyfuss,et al.  Specific Sequences of the Sm and Sm-like (Lsm) Proteins Mediate Their Interaction with the Spinal Muscular Atrophy Disease Gene Product (SMN)* , 2000, The Journal of Biological Chemistry.

[21]  M. James,et al.  Long-term stability of large insert genomic DNA episomal shuttle vectors in human cells. , 1999, Nucleic Acids Research.

[22]  R. Athwal,et al.  Identification of a gene at 16q24.3 that restores cellular senescence in immortal mammary tumor cells , 1999, Oncogene.

[23]  F. Wright,et al.  Pooled analysis of loss of heterozygosity in breast cancer: a genome scan provides comparative evidence for multiple tumor suppressors and identifies novel candidate regions. , 2003, American journal of human genetics.

[24]  D. Shelton,et al.  Microarray analysis of replicative senescence , 1999, Current Biology.

[25]  C Roskelley,et al.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[26]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[27]  M. Pagano,et al.  Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase. , 2004, Nature.

[28]  Chi-Ying F. Huang,et al.  Fbx7 Functions in the SCF Complex Regulating Cdk1-Cyclin B-phosphorylated Hepatoma Up-regulated Protein (HURP) Proteolysis by a Proline-rich Region*[boxs] , 2004, Journal of Biological Chemistry.

[29]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[30]  J. Minna,et al.  Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers , 2002, Oncogene.

[31]  Michele Pagano,et al.  The F-box protein family , 2000, Genome Biology.